Table 4.
Correlation of the Patient Benefit Index Questionnaire for Allergen Immunotherapy with Other Outcome Variables. Only Patients with Allergen Immunotherapy at t5
| r | n | p | |
|---|---|---|---|
| Current severity assessed by physician (0 = no ARC to 4 = very strong ARC) | −0.26 | 325 | 0.000 |
| Current severity assessed by the patient (0 = not bothersome at all to 10 = extremely bothersome) | −0.37 | 329 | 0.000 |
| RQLQ global score (0 = not at all to 6 = extremely impaired by the disease in QoL) | −0.35 | 331 | 0.000 |
| EQ VAS: current health status (0 = worst imaginable health state to 100 = best imaginable health state) | 0.27 | 327 | 0.000 |
| Satisfaction with previous treatment (1 = very satisfied to 4 = not at all satisfied) | −0.57 | 314 | 0.000 |
Abbreviations: ARC, allergic rhinoconjunctivitis; EQ VAS, European quality of life visual analogue scale; RQLQ, Rhinoconjunctivitis Quality of Life Questionnaire; QoL, quality of life.